1. Home
  2. HUBC vs BOLD Comparison

HUBC vs BOLD Comparison

Compare HUBC & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hub Cyber Security Ltd.

HUBC

Hub Cyber Security Ltd.

HOLD

Current Price

$0.36

Market Cap

25.0M

Sector

N/A

ML Signal

HOLD

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

HOLD

Current Price

$1.23

Market Cap

26.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUBC
BOLD
Founded
2017
2018
Country
Israel
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
25.0M
26.9M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
HUBC
BOLD
Price
$0.36
$1.23
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.00
AVG Volume (30 Days)
2.3M
127.7K
Earning Date
05-01-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$28,966,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.32
$1.00
52 Week High
$14.00
$2.77

Technical Indicators

Market Signals
Indicator
HUBC
BOLD
Relative Strength Index (RSI) 26.43 56.47
Support Level $0.35 $1.14
Resistance Level $0.44 $1.24
Average True Range (ATR) 0.06 0.08
MACD 0.03 0.00
Stochastic Oscillator 35.66 46.00

Price Performance

Historical Comparison
HUBC
BOLD

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: